Aggravation of 6-hydroxydopamine-induced dopaminergic lesions in metallothionein-I and -II knock-out mouse brain
- 12 July 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 327 (1) , 61-65
- https://doi.org/10.1016/s0304-3940(02)00346-4
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 11 references indexed in Scilit:
- Altered Central Nervous System Cytokine-Growth Factor Expression Profiles and Angiogenesis in Metallothionein-I+II Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- CNS Wound Healing Is Severely Depressed in Metallothionein I- and II-Deficient MiceJournal of Neuroscience, 1999
- Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic miceNeuroscience, 1998
- Antioxidant activity of metallothionein compared with reduced glutathioneLife Sciences, 1997
- ROLE OF METALLOTHIONEIN AND OTHER ANTIOXIDANTS IN SCAVENGING SUPEROXIDE RADICALS AND THEIR POSSIBLE ROLE IN NEUROPROTECTIONNeurochemistry International, 1996
- Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitroBrain Research, 1994
- Changes in lipid peroxidation, Cu/Zn-superoxide dismutase and its mRNA following an intracerebroventricular injection of 6-hydroxydopamine in miceBrain Research, 1994
- Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamineNeuroscience Letters, 1994
- Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium.Proceedings of the National Academy of Sciences, 1994
- Reactive Oxygen Species and the Central Nervous SystemJournal of Neurochemistry, 1992